Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0LIB.L Stock Summary
Top 10 Correlated ETFs
0LIB.L
In the News
0LIB.L Financial details
Company Rating
Strong Buy
Market Cap
25.3B
Income
1.29B
Revenue
11.21B
Book val./share
47
Cash/share
15.81
Dividend
-
Dividend %
-
Employees
18.5K
Optionable
No
Shortable
Yes
Earnings
30 May 2024
P/E
19.15
Forward P/E
19.56
PEG
22.91
P/S
2.2
P/B
11.78
P/C
33.17
P/FCF
24.19
Quick Ratio
0.38
Current Ratio
1.69
Debt / Equity
0.12
LT Debt / Equity
-
-
-
EPS (TTM)
26.19
EPS next Y
26.81
EPS next Q
5.62
EPS this Y
8.32%
EPS next Y
2.38%
EPS next 5Y
68.69%
EPS last 5Y
16.48%
Revenue last 5Y
8.66%
Revenue Q/Q
42.8%
EPS Q/Q
59.72%
-
-
-
-
SMA20
-5.21%
SMA50
9.27%
SMA100
37.05%
Inst Own
-
Inst Trans
-
ROA
24%
ROE
64%
ROC
0.44%
Gross Margin
43%
Oper. Margin
15%
Profit Margin
12%
Payout
-
Shs Outstand
48.56M
Shs Float
48.46M
-
-
-
-
Target Price
-
52W Range
367.81-572.12
52W High
-8.31%
52W Low
+42.91%
RSI
46.25
Rel Volume
0.35
Avg Volume
1.05K
Volume
369
Perf Week
-0.4%
Perf Month
0.48%
Perf Quarter
33.54%
Perf Half Y
33.98%
-
-
-
-
Beta
1.311
-
-
Volatility
6.92%, 15.44%
Prev Close
2.7%
Price
524.47
Change
1.83%
0LIB.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2024-01-31
Metric | History | 2020-02-01 | 2021-01-30 | 2022-01-29 | 2023-01-28 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 127.91 | 109.17 | 158.42 | 198.6 | 227.31 | |
Net income per share | 12.21 | 3.12 | 18.09 | 24.17 | 26.18 | |
Operating cash flow per share | 19.04 | 14.38 | 19.44 | 28.83 | 36.8 | |
Free cash flow per share | 13.88 | 11.69 | 16.28 | 22.76 | 27.97 | |
Cash per share | 8.68 | 18.56 | 7.92 | 14.35 | 15.55 | |
Book value per share | 32.89 | 35.48 | 28.18 | 38.13 | 46.23 | |
Tangible book value per share | 32.64 | 35.25 | 27.95 | 37.89 | 46.01 | |
Share holders equity per share | 32.89 | 35.48 | 28.18 | 38.13 | 46.23 | |
Interest debt per share | 4.14 | 4.6 | 5.06 | 5.51 | 5.76 | |
Market cap | 20.97B | 20.43B | 19.36B | 26.1B | 24.88B | |
Enterprise value | 22.51B | 21.28B | 20.98B | 27.26B | 26.02B | |
P/E ratio | 29.7 | 116.18 | 19.64 | 21.01 | 19.27 | |
Price to sales ratio | 2.83 | 3.32 | 2.24 | 2.56 | 2.22 | |
POCF ratio | 19.04 | 25.21 | 18.28 | 17.61 | 13.71 | |
PFCF ratio | 26.12 | 31.02 | 21.83 | 22.31 | 18.04 | |
P/B Ratio | 11.02 | 10.22 | 12.61 | 13.32 | 10.92 | |
PTB ratio | 11.02 | 10.22 | 12.61 | 13.32 | 10.92 | |
EV to sales | 3.04 | 3.46 | 2.43 | 2.67 | 2.32 | |
Enterprise value over EBITDA | 18.52 | 34.8 | 13.81 | 14.42 | 13.48 | |
EV to operating cash flow | 20.44 | 26.26 | 19.8 | 18.4 | 14.34 | |
EV to free cash flow | 28.05 | 32.31 | 23.65 | 23.31 | 18.87 | |
Earnings yield | 0.03 | 0.01 | 0.05 | 0.05 | 0.05 | |
Free cash flow yield | 0.04 | 0.03 | 0.05 | 0.04 | 0.06 | |
Debt to equity | 0.13 | 0.13 | 0.18 | 0.14 | 0.12 | |
Debt to assets | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | |
Net debt to EBITDA | 1.27 | 1.39 | 1.06 | 0.62 | 0.59 | |
Current ratio | 1.81 | 1.87 | 1.46 | 1.61 | 1.71 | |
Interest coverage | 0 | 54.71 | 752 | 0 | 0 | |
Income quality | 1.56 | 4.61 | 1.07 | 1.19 | 1.41 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0.04 | |
Payout ratio | 0 | 0.61 | 0 | 0 | 0.78 | |
Sales general and administrative to revenue | 0 | 0.28 | 0.24 | 0.24 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.27 | -0.19 | -0.16 | -0.21 | -0.24 | |
Capex to revenue | -0.04 | -0.02 | -0.02 | -0.03 | -0.04 | |
Capex to depreciation | -1.01 | -0.51 | -0.64 | -1.29 | -1.79 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | -0.06 | |
Graham number | 95.03 | 49.91 | 107.11 | 143.99 | 165.04 | |
ROIC | 0.19 | 0.06 | 0.28 | 0.32 | 0.31 | |
Return on tangible assets | 0.13 | 0.03 | 0.18 | 0.21 | 0.23 | |
Graham Net | -39.7 | -33.65 | -44.99 | -45.64 | -33.14 | |
Working capital | 918.06M | 1.17B | 723.17M | 1.03B | 1.18B | |
Tangible asset value | 1.89B | 1.99B | 1.52B | 1.95B | 2.27B | |
Net current asset value | -1.49B | -1.16B | -1.53B | -1.33B | -591.17M | |
Invested capital | 0.13 | 0.13 | 0.18 | 0.14 | 0.12 | |
Average receivables | 137.75M | 166.22M | 213.4M | 216.55M | 203.68M | |
Average payables | 409.01M | 445.53M | 514.89M | 556.13M | 551.76M | |
Average inventory | 1.25B | 1.23B | 1.33B | 1.55B | 1.67B | |
Days sales outstanding | 6.87 | 11.46 | 9.88 | 7.13 | 6.77 | |
Days payables outstanding | 32.04 | 41.43 | 38.34 | 33.13 | 29.09 | |
Days of inventory on hand | 100.11 | 101.46 | 103.99 | 94.95 | 93.15 | |
Receivables turnover | 53.09 | 31.86 | 36.93 | 51.19 | 53.9 | |
Payables turnover | 11.39 | 8.81 | 9.52 | 11.02 | 12.55 | |
Inventory turnover | 3.65 | 3.6 | 3.51 | 3.84 | 3.92 | |
ROE | 0.37 | 0.09 | 0.64 | 0.63 | 0.57 | |
Capex per share | -5.16 | -2.7 | -3.16 | -6.07 | -8.83 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q4
Metric | History | 2023-01-28 | 2023-04-29 | 2023-07-29 | 2023-10-28 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 63.74 | 52.52 | 50.99 | 50.79 | 73.28 | |
Net income per share | 6.73 | 6.92 | 6.05 | 5.09 | 8.13 | |
Operating cash flow per share | 17.95 | 6.08 | 2.5 | -1.44 | 30.03 | |
Free cash flow per share | 15.81 | 3.89 | 0.58 | -3.61 | 27.47 | |
Cash per share | 14.58 | 12.69 | 7.83 | 2.49 | 15.81 | |
Book value per share | 38.71 | 40.24 | 41.35 | 41.39 | 47 | |
Tangible book value per share | 38.47 | 40 | 41.12 | 41.16 | 46.77 | |
Share holders equity per share | 38.71 | 40.24 | 41.35 | 41.39 | 47 | |
Interest debt per share | 5.6 | 5.75 | 5.79 | 9.86 | 5.85 | |
Market cap | 25.7B | 27.53B | 22.12B | 18.7B | 24.47B | |
Enterprise value | 26.87B | 28.79B | 23.61B | 20.68B | 25.62B | |
P/E ratio | 18.86 | 19.83 | 18.43 | 18.74 | 15.51 | |
Price to sales ratio | 7.97 | 10.45 | 8.74 | 7.51 | 6.89 | |
POCF ratio | 28.29 | 90.3 | 178.52 | -264.19 | 16.8 | |
PFCF ratio | 32.12 | 141.09 | 764.75 | -105.63 | 18.37 | |
P/B Ratio | 13.12 | 13.64 | 10.78 | 9.22 | 10.74 | |
PTB ratio | 13.12 | 13.64 | 10.78 | 9.22 | 10.74 | |
EV to sales | 8.33 | 10.93 | 9.33 | 8.31 | 7.21 | |
Enterprise value over EBITDA | 52.79 | 57.51 | 51.91 | 52.75 | 43.96 | |
EV to operating cash flow | 29.58 | 94.44 | 190.56 | -292.13 | 17.59 | |
EV to free cash flow | 33.57 | 147.56 | 816.32 | -116.8 | 19.23 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | 0.03 | 0.01 | 0 | -0.01 | 0.05 | |
Debt to equity | 0.14 | 0.14 | 0.14 | 0.24 | 0.12 | |
Debt to assets | 0.05 | 0.05 | 0.05 | 0.09 | 0.05 | |
Net debt to EBITDA | 2.29 | 2.52 | 3.28 | 5.04 | 1.96 | |
Current ratio | 1.61 | 1.64 | 1.69 | 1.52 | 1.71 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 2.67 | 0.88 | 0.41 | -0.28 | 3.69 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0.35 | 0 | |
Sales general and administrative to revenue | 0.25 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.12 | -0.36 | -0.77 | 1.5 | -0.09 | |
Capex to revenue | -0.03 | -0.04 | -0.04 | -0.04 | -0.03 | |
Capex to depreciation | -1.83 | -1.89 | -1.53 | -1.73 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 76.57 | 79.15 | 75.02 | 68.86 | 92.73 | |
ROIC | 0.09 | 0.09 | 0.08 | 0.06 | 0.09 | |
Return on tangible assets | 0.06 | 0.06 | 0.06 | 0.04 | 0.07 | |
Graham Net | -46.34 | -33.95 | -35.67 | -43.5 | -33.69 | |
Working capital | 1.03B | 1.05B | 1.03B | 955.1M | 1.18B | |
Tangible asset value | 1.95B | 2.01B | 2.04B | 2.02B | 2.27B | |
Net current asset value | -1.33B | -671.67M | -677.64M | -774.43M | -591.17M | |
Invested capital | 0.14 | 0.14 | 0.14 | 0.24 | 0.12 | |
Average receivables | 199.86M | 194.85M | 182.36M | 188.66M | 205.4M | |
Average payables | 603.32M | 590.4M | 571.29M | 559.34M | 570.69M | |
Average inventory | 1.86B | 1.68B | 1.78B | 2.07B | 2.03B | |
Days sales outstanding | 5.56 | 6.5 | 6.21 | 7.34 | 5.27 | |
Days payables outstanding | 25 | 35.4 | 30.54 | 35.92 | 22.12 | |
Days of inventory on hand | 71.64 | 99.79 | 106.37 | 139.57 | 70.83 | |
Receivables turnover | 16.18 | 13.84 | 14.5 | 12.27 | 17.09 | |
Payables turnover | 3.6 | 2.54 | 2.95 | 2.51 | 4.07 | |
Inventory turnover | 1.26 | 0.9 | 0.85 | 0.64 | 1.27 | |
ROE | 0.17 | 0.17 | 0.15 | 0.12 | 0.17 | |
Capex per share | -2.14 | -2.19 | -1.91 | -2.17 | -2.56 |
0LIB.L Frequently Asked Questions
What is Ulta Beauty, Inc. stock symbol ?
Ulta Beauty, Inc. is a US stock , located in Bolingbrook of Il and trading under the symbol 0LIB.L
What is Ulta Beauty, Inc. stock quote today ?
Ulta Beauty, Inc. stock price is $524.47 today.
Is Ulta Beauty, Inc. stock public?
Yes, Ulta Beauty, Inc. is a publicly traded company.